Facebook
Twitter
LinkedIn
Forward
Multiple Sclerosis Symposium Clinical Advances of Multiple Sclerosis Diagnosis and Treatment
Multiple Sclerosis is the second leading cause of disability in young adults 25-50 years old. A comprehensive approach to disease identification and management is required to navigate myriad complexities of this disease. Our course will highlight practice specifications, most up-to-date treatment protocols, recent advances in the field and physical therapy evaluation and management. Presentations will refer to current literature, technical developments, methodologies, and clinical efficacy. The information presented will aid collaboration between neurology practices to increase clinical acumen on MS and other neuro-immunological conditions that may mimic this disease, fine tune the clinical and radiographic assessment process for diagnosis and provide information on outcome and long-term management standards.
Target Audience
The conference is designed for advanced professionals involved in treating patients with multiple sclerosis and other neuro-immunological disorders including, but not limited to, Neurologists, PM&R physicians, Advanced Practice Providers, Nursing staff and Physical Therapists. Medical students, Residents and Fellows are also invited.
Learning Objectives
Identify lesions on imaging (MRIs) typical for MS diagnosis.
Differentiation of MS mimickers on imaging studies.
First line serum and CSF studies to order and how to interpret test results in the diagnosis of MS.
Autoimmune Encephalitis as a differential diagnosis
Pregnancy and MS
Leukodystrophies
Utlization of Physical Therapy in MS
Utilize community resources to support mental health associated with newly diagnosed MS; socioeconomic issues related to treatment of MS.
Enroll patients in studies both local, continental and global research studies to enhance understanding of MS outcomes.
COURSE DIRECTOR
INGRID LOMA-MILLER, MD
Assistant Professor of Neurology and Assistant Division Chief of MS/Neuroimmunology UPMC Magee-Womens Hospital
COURSE CO-DIRECTOR
EMILY GUERRIERO PA-C
Supervisor Physician Assistant of Neurology MS Care Center/Neuroimmunology
UPMC Magee-Womens Hospital
DARCY BONAVENTURA, PT, DPT
Board-certified Neurologic Clinical Specialist
PT Program Director, UPMC Rehabilitation
Joseph Mettenburg, MD PhD
Neuroradiologist and Diagnostic Radiologist
UPMC
ROCK HEYMAN, MD
Director of the MS Care Center and Chief of the Division of Neuroimmunology
UPMC Magee-Womens Hospital
CIGDEM ISITAN ALKAWADRI, MD
Assistant Professor of Neurology MS Care Center and Co-director Fellowship Program
UPMC Magee-Womens Hospital
HOLLY APPLEBERRY, DO, MBA
Assistant Professor of Neurology MS Care Center Division of Neuroimmunology
UPMC Magee-Womens Hospital
JENNY LINNOILA, MD, PhD
Neurology Faculty MS Care Center Division of Neuroimmunology
UPMC Magee-Womens Hospital
Faculty Disclosure:
Faculty Disclosure:
All individuals in a position to control the content of this education activity have disclosed all financial relationships with any companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All the relevant financial relationships for the individuals listed below have been mitigated
Ingrid Loma-Miller has grant/research support with Novartis and is a consultant with Genentech & Serono.
Holly Appleberry has grant/research support with Genentech. She is also on the medical advisory board with Genentech & Horizon.
Emily Guerriero was on the advisory board with Amgen.
No other members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships with any companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician (CME)
The University of Pittsburgh designates this live activity for a maximum of 7.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing (CNE)
The maximum number of hours awarded for this Continuing Nursing Education activity is 7.5 contact hours.
Physician Assistant (AAPA)
The University of Pittsburgh has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 7.5 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
Available Credit
- 7.50 AAPA Category I CME
- 7.50 AMA PRA Category 1 Credit™The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
- 7.50 ANCCUPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
- 7.50 Attendance